Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial

LIONETTI, E., MINIELLO, V. L., CASTELLANETA, S. P., MAGISTÁ, A. M., DE CANIO, A., MAUROGIOVANNI, G., IERARDI, E., CAVALLO, L., FRANCAVILLA, R. · 2006 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Helicobacter pylori eradication fails in about 25–30% of children, particularly because of the occurrence of resistance to antibiotics and side‐effects. Aim: To determine whether adding the Lactobacillus reuteri to an anti‐H. pylori regimen could help to prevent or minimize the gastrointestinal side‐effects burden in children. Methods: Forty H. pylori‐positive children (21 males; median age: 12.3 years) were consecutively treated with 10‐day sequential therapy [omeprazole + amoxycillin for 5 days, and omeprazole + clarithromycin + tinidazole for other 5 days] and blindly randomized to receive either L. reuteri ATCC 55730 (10 8 CFU) or placebo. All children completed the Gastrointestinal Symptom Rating Scale (GSRS) at entry, during and after treatment. H. pylori status was assessed after 8 weeks by 13 C‐urea breath test. Results: Overall, in all probiotic supplemented children when compared with those receiving placebo there was a significant reduction of GSRS score during eradication therapy (4.1 ± 2 vs. 6.2 ± 3; P < 0.01) and at the end of follow‐up (3.2 ± 2 vs. 5.8 ± 3.4; P < 0.009). Overall, children receiving L. reuteri report less symptoms than those receiving placebo. Conclusion: L. reuteri is capable of reducing frequency and intensity of antibiotic‐associated side‐effects during eradication therapy for H. pylori.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2006.03145.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 169

Metadata

Authors
LIONETTI, E., MINIELLO, V. L., CASTELLANETA, S. P., MAGISTÁ, A. M., DE CANIO, A., MAUROGIOVANNI, G., IERARDI, E., CAVALLO, L., & FRANCAVILLA, R.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2006-10-10
Volume
24
Issue
10
Pages
1461-1468
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2086771104
Cited by
169
References
2
FWCI
14.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.03145.x
The paper
LIONETTI, E., MINIELLO, V. L., CASTELLANETA, S. P., MAGISTÁ, A. M., DE CANIO, A., MAUROGIOVANNI, G., IERARDI, E., CAVALLO, L., & FRANCAVILLA, R. (2006). Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.03145.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.